The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
Patients & Carers meeting May 2015
January 10, 2019
Patients & Carers meeting March 2015
January 10, 2019
Patients & Carers meeting February 2015
January 10, 2019
Patients & Carers meeting December 2014
January 10, 2019
Patients & Carers meeting November 2014
January 10, 2019
Patients & Carers meeting October 2014
January 10, 2019
Patients & Carers meeting September 2014
January 10, 2019
Patients & Carers meeting January 2014
January 10, 2019
Patients & Carers meeting December 2013
January 10, 2019
Patients & Carers meeting November 2013
January 10, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video